Renovaro Biosciences Inc. (RENB)
NASDAQ: RENB · IEX Real-Time Price · USD
1.350
-0.050 (-3.57%)
At close: Jul 19, 2024, 4:00 PM
1.260
-0.090 (-6.67%)
Pre-market: Jul 22, 2024, 4:05 AM EDT
Renovaro Biosciences Market Cap
Renovaro Biosciences has a market cap or net worth of $199.13 million as of July 22, 2024. Its market cap has increased by 648.62% in one year.
Market Cap
199.13M
Enterprise Value
207.39M
1-Year Change
648.62%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since December 11, 2018, Renovaro Biosciences's market cap has decreased from $252.00M to $199.13M, a decrease of -20.98%. That is a compound annual growth rate of -4.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 199.10M | -5.82% |
| Dec 29, 2023 | 211.40M | 287.89% |
| Dec 30, 2022 | 54.50M | -85.68% |
| Dec 31, 2021 | 380.70M | 176.67% |
| Dec 31, 2020 | 137.60M | -40.77% |
| Dec 31, 2019 | 232.30M | -8.25% |
| Dec 31, 2018 | 253.20M | 0.48% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biodesix | 202.99M |
| bluebird bio | 202.38M |
| CVRx, Inc. | 202.13M |
| Outset Medical | 200.17M |
| Personalis | 199.96M |
| P3 Health Partners | 197.60M |
| Trevi Therapeutics | 195.81M |
| ClearPoint Neuro | 193.86M |